Representative batches? [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2010-08-05 12:45  – Posting: # 5726
Views: 9,130

Dear Dan!

» But can you argue with the assessor without statistics?

Statistics – A subject which most statisticians find difficult
but in which nearly all physicians are expert.
Stephen Senn

EMEA. The European Medicines Evaluation Agency.
The drug regulatory agency of the European Union.
A statistician-free zone.
Stephen Senn; Statistical Issues in Drug Development. Wiley, p386, 2004


» As other sponsors we selected T & R batches which matched closely. Comparative dissolution profiles showed similarity and the assay content differed less than 5%.
» From the quality point of view we see no difference between the batches.

Yes, everybody did/does it that way (see also the last paragraph in ElMaestro’s post). Of course that's not representative, but 'best'.

» The logic consequence would be that for the release of any batch you produce for the market you have to perform a BE study as quality control.

Yes, but would be applicable to the innovator as well. I would remind the assessor that this idea was already abandoned 15+ years ago and on the consequences.

Cheers,
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. ☼
Science Quotes

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,567 posts in 4,150 threads, 1,341 registered users;
online 10 (1 registered, 9 guests [including 6 identified bots]).
Forum time (Europe/Vienna): 10:27 CEST

Power. That which statisticians are always calculating
but never have.    Stephen Senn

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5